CAN
SYRS

Claraphi Advisory Network’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Claraphi Advisory Network’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,800
Closed -$214K – 281
2018
Q3 		$214K Buy
1,800
+200
+13% +$23.8K 0.12% 227
2018
Q2 		$163K Buy
+1,600
New +$163K 0.11% 251